ProCE Banner Activity

Evolution of Immunotherapy and Maintenance Therapy for Advanced Urothelial Carcinoma

Slideset Download
Learn about the most clinically influential developments in leveraging immune checkpoint inhibitor–based therapy for first-line, second-line, and maintenance treatment of advanced urothelial carcinoma.

Released: February 26, 2021

Expiration: February 25, 2022

No longer available for credit.

Share

Faculty

Cora N. Sternberg

Cora N. Sternberg, MD

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Immunomedics

Faculty Disclosure

Primary Author

Cora N. Sternberg, MD